Amiodarone Injection Shortage
Last Updated: October 26, 2024
Status: Current
Products Affected - Description
-
- Nexterone injection, Baxter, 150 mg/100 mL, premixed bag, 12 count, NDC 43066-0150-10
- Nexterone injection, Baxter, 360 mg/200 mL, premixed bag, 10 count, NDC 43066-0360-20
- Amiodarone injection, Fresenius Kabi, 50 mg/mL, 3 mL vial, 10 count, NDC 63323-0616-03
- Amiodarone injection, Hikma, 50 mg/mL, 3 mL vial, 25 count, NDC 00143-9875-25
Reason for the Shortage
-
- AuroMedics discontinued amiodarone in mid-2021.
- Baxter has Nexterone premixed bags on shortage due to manufacturing delays.
- Fresenius Kabi did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.
- Viatris did not provide a reason for the shortage.
- Sagent discontinued amiodarone 50 mg/mL 3 mL syringes in June 2019.
Available Products
-
- Amiodarone injection, Fresenius Kabi, 50 mg/mL, 9 mL vial, 10 count, NDC 63323-0616-09
- Amiodarone injection, Mylan Institutional (Viatris), 50 mg/mL, 18 mL vial, 10 count, NDC 67457-0153-18
- Amiodarone injection, Mylan Institutional (Viatris), 50 mg/mL, 3 mL vial, 10 count, NDC 67457-0153-03
- Amiodarone injection, Mylan Institutional (Viatris), 50 mg/mL, 9 mL vial, 10 count, NDC 67457-0153-09
Estimated Resupply Dates
-
- Fresenius Kabi has amiodarone 50 mg/mL 3 mL vials on back order and the company cannot estimate a release date.
- Hikma has amiodarone 50 mg/mL 3 mL vials on allocation.
- Baxter has Nexterone 150 mg/100 mL premixes and 360 mg/200 mL premixes on allocation.
Updated
Updated October 26, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.